Synchron Stock
HealthTechLooking to sell Synchron stock or options?
Synchron has developed an implantable stentrode aimed at establishing a brain-computer interface. This innovative company provides a minimally invasive device equipped with electrode arrays that decode brain signals to influence neural activity in targeted areas. This technology empowers patients with motor impairments to regain some control over digital devices, prosthetics, or other assistive technologies using just their thoughts.
Bezos Expeditions, Project X, Greenoaks Capital Partners, Arani Bose, Moore Strategic Ventures, Forepont Capital Partners, Metis Innovative, re.Mind Capital, Defense Advanced Research Projects Agency, Thomas Reardon, United States Department of Defense, MTPConnect, ARCH Venture Partners, Khosla Ventures, National Institutes of Health, Mind Capital, Green Sands Equity, General Advance, Reliance Digital Health, The University of Melbourne Endowment, Gates Family Foundation, Jumpspace Ventures, ID8 Investments, Shanda Group, Alumni Ventures.